Key result
Human gene (albumin) amplification identified 13.0% of samples as inhibited compared to 2.0% by pathogen-specific controls, demonstrating that human gene-based qPCR is inadequate for detecting PCR inhibitors.
Why the study?
Does pathogen-specific amplification improve the detection of PCR inhibition compared to human gene amplification in microbiological samples?
Observational (n=3,152)
No
Does pathogen-specific amplification improve the detection of PCR inhibition compared to human gene amplification in microbiological samples?
Absolute Event Rate: 13% vs 2%
qPCR targeting the albumin gene is not adequate to identify the presence of PCR inhibitors in microbiological PCR assays compared to pathogen-specific controls.
Albumin-based qPCR underestimates PCR inhibition versus pathogen-specific controls; leaves open whether routine adoption improves diagnostic yield.
PCR inhibition is frequent in medical microbiology routine practice and may lead to false-negative results; however there is no consensus on how to detect it. Pathogen-specific and human gene amplifications are widely used to detect PCR inhibition. We aimed at comparing the value of PCR inhibitor detection using these two methods. We analysed Cp shifts (ΔCp) obtained from qPCRs targeting either the albumin gene or the pathogen-specific sequence used in two laboratory-developed microbiological qPCR assays. 3152 samples including various matrixes were included. Pathogen-specific amplification and albumin qPCR identified 62/3152 samples (2.0 %), and 409/3152 (13.0%) samples, respectively, as inhibited. Only 16 samples were detected using both methods. In addition, the use of the Youden’s index failed to determine adequate Cp thresholds for albumin qPCR, even when we distinguished among the different sample matrixes. qPCR targeting the albumin gene therefore appears not adequate to identify the presence of PCR inhibitors in microbiological PCR assays. Our data may be extrapolated to other heterologous targets and should discourage their use to assess the presence of PCR inhibition in microbiological PCR assays.
No takes yet. Share an insight, caveat, or question.
Roux et al. (2019) conducted an observational in Infectious diseases (Toxoplasmosis and Pneumocystis) (n=3,152). Human gene (albumin) amplification control vs. Pathogen-specific amplification control was evaluated on Detection of PCR inhibition. Human gene (albumin) amplification identified 13.0% of samples as inhibited compared to 2.0% by pathogen-specific controls, demonstrating that human gene-based qPCR is inadequate for detecting PCR inhibitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: